Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wisplinghoff

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Mycoses|March 27, 2015
Our 2015 approach to invasive pulmonary aspergillosisB Liss, J J Vehreschild, C Bangard, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 1, 2015
Comparative in vitro activity of oral antimicrobial agents against Enterobacteriaceae from patients with community-acquired urinary tract infections in three European countriesM Kresken, B Körber-Irrgang, D J Biedenbach, et al.
Acta Neurochirurgica|January 1, 1975
Proceedings: Misdiagnosis of multiple sclerosis--cerebral form (joint report)G Lausberg, B L Farhoumand, B Collmann, et al.
Frontiers in Medicine|October 28, 2021
SARS-CoV-2 Infection in Fully Vaccinated Individuals of Old Age Strongly Boosts the Humoral Immune ResponseLisa Müller, Marcel Andrée, Philipp Niklas Ostermann, et al.
Scientific Reports|June 12, 2020
Prediction of advanced fibrosis in non-alcoholic fatty liver disease using gut microbiota-based approaches compared with simple non-invasive toolsSonja Lang, Fedja Farowski, Anna Martin, et al.
Nutrition Research (New York, N.Y.)|September 26, 2022
Dietary omega-6/omega-3 ratio is not associated with gut microbiota composition and disease severity in patients with nonalcoholic fatty liver diseaseKathrin Heinzer, Sonja Lang, Fedja Farowski, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 13, 2014
Candidemia in the intensive care unit: analysis of direct treatment costs and clinical outcome in patients treated with echinocandins or fluconazoleS M Heimann, O A Cornely, H Wisplinghoff, et al.
Journal of Gastroenterology and Hepatology|April 9, 2020
Phenotyping non-alcoholic fatty liver disease by the gut microbiota: Ready for prime time?Münevver Demir, Sonja Lang, Anna Martin, et al.
Infection|July 1, 2015
Economic burden of Clostridium difficile associated diarrhoea: a cost-of-illness study from a German tertiary care hospitalS M Heimann, J J Vehreschild, O A Cornely, et al.
The Journal of Antimicrobial Chemotherapy|August 5, 2022
Invasive Trichoderma spp. infections: clinical presentation and outcome of cases from the literature and the FungiScope® registryErtan Sal, Jannik Stemler, Jon Salmanton-García, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Mycoses|March 27, 2015
Our 2015 approach to invasive pulmonary aspergillosisB Liss, J J Vehreschild, C Bangard, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 1, 2015
Comparative in vitro activity of oral antimicrobial agents against Enterobacteriaceae from patients with community-acquired urinary tract infections in three European countriesM Kresken, B Körber-Irrgang, D J Biedenbach, et al.
Acta Neurochirurgica|January 1, 1975
Proceedings: Misdiagnosis of multiple sclerosis--cerebral form (joint report)G Lausberg, B L Farhoumand, B Collmann, et al.
Frontiers in Medicine|October 28, 2021
SARS-CoV-2 Infection in Fully Vaccinated Individuals of Old Age Strongly Boosts the Humoral Immune ResponseLisa Müller, Marcel Andrée, Philipp Niklas Ostermann, et al.
Scientific Reports|June 12, 2020
Prediction of advanced fibrosis in non-alcoholic fatty liver disease using gut microbiota-based approaches compared with simple non-invasive toolsSonja Lang, Fedja Farowski, Anna Martin, et al.
Nutrition Research (New York, N.Y.)|September 26, 2022
Dietary omega-6/omega-3 ratio is not associated with gut microbiota composition and disease severity in patients with nonalcoholic fatty liver diseaseKathrin Heinzer, Sonja Lang, Fedja Farowski, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 13, 2014
Candidemia in the intensive care unit: analysis of direct treatment costs and clinical outcome in patients treated with echinocandins or fluconazoleS M Heimann, O A Cornely, H Wisplinghoff, et al.
Journal of Gastroenterology and Hepatology|April 9, 2020
Phenotyping non-alcoholic fatty liver disease by the gut microbiota: Ready for prime time?Münevver Demir, Sonja Lang, Anna Martin, et al.
Infection|July 1, 2015
Economic burden of Clostridium difficile associated diarrhoea: a cost-of-illness study from a German tertiary care hospitalS M Heimann, J J Vehreschild, O A Cornely, et al.
The Journal of Antimicrobial Chemotherapy|August 5, 2022
Invasive Trichoderma spp. infections: clinical presentation and outcome of cases from the literature and the FungiScope® registryErtan Sal, Jannik Stemler, Jon Salmanton-García, et al.
Pageof 11